Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
[HTML][HTML] Global threat of carbapenem-resistant Gram-negative bacteria
Infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-
negative bacteria (GNB), including carbapenem-resistant (CR) Enterobacterales (CRE; …
negative bacteria (GNB), including carbapenem-resistant (CR) Enterobacterales (CRE; …
Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections
In recent years, the worldwide spread of the so-called high-risk clones of multidrug-resistant
or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public …
or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public …
Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review
M Nguyen, SG Joshi - Journal of applied microbiology, 2021 - academic.oup.com
Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …
Advances in the microbiology of Stenotrophomonas maltophilia
JS Brooke - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Stenotrophomonas maltophilia is an opportunistic pathogen of significant concern to
susceptible patient populations. This pathogen can cause nosocomial and community …
susceptible patient populations. This pathogen can cause nosocomial and community …
Clinical challenges treating Stenotrophomonas maltophilia infections: an update
Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach …
The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …
[HTML][HTML] Resistance to ceftazidime–avibactam and underlying mechanisms
Y Wang, J Wang, R Wang, Y Cai - Journal of global antimicrobial resistance, 2020 - Elsevier
Abstract Objective Ceftazidime–avibactam (CAZ-AVI) is a novel synthetic β-lactamase
inhibitor combination. Although the combination has been available clinically for only a few …
inhibitor combination. Although the combination has been available clinically for only a few …
Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents
MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …
growing concern due to limited treatment options. Knowledge of the common uropathogens …